Transaction in Own Shares

Summary by AI BETAClose X

On August 22, 2025, GSK plc, acting through Merrill Lynch International, purchased 243,639 of its own ordinary shares with a nominal value of 31¼ pence each. The lowest price paid per share was 1,479.50p, while the highest price was 1,498.50p, resulting in a volume-weighted average price of 1,487.66p. These shares will be held as treasury shares as part of an existing buyback program, which began on June 4, 2025, and has since seen the purchase of 25,272,895 ordinary shares. Following this transaction, GSK will hold 243,407,278 ordinary shares in treasury, with 4,071,985,349 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to treasury shares is 5.98 percent.

Disclaimer*

Companies

GSK (GSK)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today